About

About Clyra Medical Technologies Inc. Clyra Medical Technologies, founded on our mission of "Make Lives Better," develops and commercializes products designed to safely treat wound and skin infections and promote healing while reducing the need for antibiotics. Clyra is a subsidiary of BioLargo, Inc (OTCQB:BLGO), a technology innovator focused on human health and environmental challenges including water treatment, environmental remediation, air quality control, and medical technologies. Clyra's copper-iodine complex technology creates a gentle but effective oxidative reaction against bacteria, yeast, fungi, and viruses. Our technology is safe, effective, bio-compatible, and cost-effective. Available in multiple formats including liquid, powder, super absorbent polymer pads, and hydrogel, our products are not associated with acquired microbial resistance. They can be used by wound care centers, hospitals, nursing homes, urgent care clinics, home healthcare, military, and consumers.